Pea F - Search Results

1

The role of procalcitonin in reducing antibiotics across the surgical pathway.

Sartelli M, Ansaloni L, Bartoletti M, Catena F, Cardi M, Cortese F, Di Marzo F, Pea F, Plebani M, Rossolini GM, Sganga G, Viaggi B, Viale P. Sartelli M, et al. Among authors: pea f. World J Emerg Surg. 2021 Mar 24;16(1):15. doi: 10.1186/s13017-021-00357-0. World J Emerg Surg. 2021. PMID: 33761972 Free PMC article. Review.

2

Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose.

Pea F, Brollo L, Viale P, Pavan F, Furlanut M. Pea F, et al. J Antimicrob Chemother. 2003 Apr;51(4):971-5. doi: 10.1093/jac/dkg147. Epub 2003 Feb 25. J Antimicrob Chemother. 2003. PMID: 12654757

3

Antimicrobial agents in elective surgery: prophylaxis or "early therapy"?

Pea F, Viale P, Furlanut MI. Pea F, et al. J Chemother. 2003 Feb;15(1):3-11. doi: 10.1179/joc.2003.15.Supplement-2.3. J Chemother. 2003. PMID: 12678408 Review.

4

[What role for fluoroquinolones in intensive therapy?].

Viale P, Pea F. Viale P, et al. Among authors: pea f. J Chemother. 2003 Aug;15 Suppl 1:5-10. J Chemother. 2003. PMID: 14535066 Review. Italian. No abstract available.

5

What is the role of fluoroquinolones in intensive care?

Viale P, Pea F. Viale P, et al. Among authors: pea f. J Chemother. 2003 Nov;15 Suppl 3:5-10. doi: 10.1080/1120009x.2003.11782356. J Chemother. 2003. PMID: 14708959 Review.

6

Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: a report of 2 cases.

Pea F, Viale P, Lugano M, Pavan F, Scudeller L, Della Rocca G, Furlanut M. Pea F, et al. Am J Kidney Dis. 2004 Dec;44(6):1097-102. doi: 10.1053/j.ajkd.2004.08.032. Am J Kidney Dis. 2004. PMID: 15558532

7

Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.

Pea F, Viale P, Furlanut M. Pea F, et al. Clin Pharmacokinet. 2005;44(10):1009-34. doi: 10.2165/00003088-200544100-00002. Clin Pharmacokinet. 2005. PMID: 16176116 Review.

8

The effect of multifactorial, multidisciplinary educational interventions on appropriate use of teicoplanin.

Pea F, Viale P, Pavan F, Tavio M, Poz D, Beltrame A, Furlanut M. Pea F, et al. Int J Antimicrob Agents. 2006 Apr;27(4):344-50. doi: 10.1016/j.ijantimicag.2005.11.012. Epub 2006 Mar 22. Int J Antimicrob Agents. 2006. PMID: 16554146

9

The antimicrobial therapy puzzle: could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients?

Pea F, Viale P. Pea F, et al. Clin Infect Dis. 2006 Jun 15;42(12):1764-71. doi: 10.1086/504383. Epub 2006 May 10. Clin Infect Dis. 2006. PMID: 16705585 Review.

10

Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective.

Pea F, Poz D, Viale P, Pavan F, Furlanut M. Pea F, et al. J Antimicrob Chemother. 2006 Aug;58(2):380-6. doi: 10.1093/jac/dkl226. Epub 2006 May 30. J Antimicrob Chemother. 2006. PMID: 16735422

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

309 results

Search Page

Filters